8-K
Current Report
Avalo Therapeutics, Inc. Filed Acc 0001628280-23-025293
Material agreement · Debt accelerated · Other events
- Item 1.01 Entry into a material definitive agreement
- Item 2.04 Triggering events that accelerate or increase an obligation
- Item 8.01 Other events
From the SEC's structured data for this filing
Loading avtx-20230720.htm…